Janssen Pharmaceutical Companies of Johnson & Johnson, together with a consortium of global partners, have announced that an independent data review of the Phase 3 Mosaico study of Janssen’s investigational HIV vaccine regimen was not effective in preventing HIV infection among the study participants. The study will be discontinued and further analysis of the data will be conducted. They revealed no safety issues with the vaccine regimen were identified during the trial. The consortium of global partners
The COVID-19 vaccine by Johnson & Johnson is on track to become the latest vaccine in the global fight against COVI-19. Today (Wednesday), the US FDA released its report on the vaccine and you can read the entire 62 pages below. FDA-Briefing-Document According to the document, in the study that involved about 40,000 participants, as of February 5, 2021, there were 7 COVID-19 related deaths in the study in the placebo group and no COVID-19-related